Global Rheumatoid Arthritis Diagnostic Tests Market Research Report 2023

Publication ID:

PB503231835

Publication Date:

March 1, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Rheumatoid arthritis (RA) is an autoimmune disease in which the body鈥檚 own immune system attacks its joint tissues, which leads to inflammation of joint lining. Such inflammation of joint lining causes pain, stiffness, swelling, warmth, and redness.
Highlights
The global Rheumatoid Arthritis Diagnostic Tests market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Rheumatoid Arthritis Diagnostic Tests is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Rheumatoid Arthritis Diagnostic Tests is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Rheumatoid Arthritis Diagnostic Tests in Diagnostic Laboratories is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Rheumatoid Arthritis Diagnostic Tests include Abbott Diagnostics, Beckman Coulter, Euro Diagnostica, Hoffmann-La Roche, Qiagen, Siemens Healthcare, Thermo Fisher Scientific, Bio Rad Laboratories and Aviva Systems Biology, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Diagnostic Tests.
The Rheumatoid Arthritis Diagnostic Tests market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Rheumatoid Arthritis Diagnostic Tests market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rheumatoid Arthritis Diagnostic Tests companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Diagnostics
Beckman Coulter
Euro Diagnostica
Hoffmann-La Roche
Qiagen
Siemens Healthcare
Thermo Fisher Scientific
Bio Rad Laboratories
Aviva Systems Biology
Segment by Type
Serology Tests
Monitoring RA Treatment Efficiency Tests
Segment by Application
Diagnostic Laboratories
Ambulatory Surgical Centers
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rheumatoid Arthritis Diagnostic Tests companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatoid Arthritis Diagnostic Tests Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Serology Tests
1.2.3 Monitoring RA Treatment Efficiency Tests
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Diagnostic Tests Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnostic Laboratories
1.3.3 Ambulatory Surgical Centers
1.3.4 Hospitals
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rheumatoid Arthritis Diagnostic Tests Market Perspective (2018-2029)
2.2 Rheumatoid Arthritis Diagnostic Tests Growth Trends by Region
2.2.1 Global Rheumatoid Arthritis Diagnostic Tests Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Rheumatoid Arthritis Diagnostic Tests Historic Market Size by Region (2018-2023)
2.2.3 Rheumatoid Arthritis Diagnostic Tests Forecasted Market Size by Region (2024-2029)
2.3 Rheumatoid Arthritis Diagnostic Tests Market Dynamics
2.3.1 Rheumatoid Arthritis Diagnostic Tests Industry Trends
2.3.2 Rheumatoid Arthritis Diagnostic Tests Market Drivers
2.3.3 Rheumatoid Arthritis Diagnostic Tests Market Challenges
2.3.4 Rheumatoid Arthritis Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatoid Arthritis Diagnostic Tests Players by Revenue
3.1.1 Global Top Rheumatoid Arthritis Diagnostic Tests Players by Revenue (2018-2023)
3.1.2 Global Rheumatoid Arthritis Diagnostic Tests Revenue Market Share by Players (2018-2023)
3.2 Global Rheumatoid Arthritis Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rheumatoid Arthritis Diagnostic Tests Revenue
3.4 Global Rheumatoid Arthritis Diagnostic Tests Market Concentration Ratio
3.4.1 Global Rheumatoid Arthritis Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Diagnostic Tests Revenue in 2022
3.5 Rheumatoid Arthritis Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Rheumatoid Arthritis Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Rheumatoid Arthritis Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatoid Arthritis Diagnostic Tests Breakdown Data by Type
4.1 Global Rheumatoid Arthritis Diagnostic Tests Historic Market Size by Type (2018-2023)
4.2 Global Rheumatoid Arthritis Diagnostic Tests Forecasted Market Size by Type (2024-2029)
5 Rheumatoid Arthritis Diagnostic Tests Breakdown Data by Application
5.1 Global Rheumatoid Arthritis Diagnostic Tests Historic Market Size by Application (2018-2023)
5.2 Global Rheumatoid Arthritis Diagnostic Tests Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Rheumatoid Arthritis Diagnostic Tests Market Size (2018-2029)
6.2 North America Rheumatoid Arthritis Diagnostic Tests Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Rheumatoid Arthritis Diagnostic Tests Market Size by Country (2018-2023)
6.4 North America Rheumatoid Arthritis Diagnostic Tests Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Diagnostic Tests Market Size (2018-2029)
7.2 Europe Rheumatoid Arthritis Diagnostic Tests Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Rheumatoid Arthritis Diagnostic Tests Market Size by Country (2018-2023)
7.4 Europe Rheumatoid Arthritis Diagnostic Tests Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rheumatoid Arthritis Diagnostic Tests Market Size (2018-2029)
8.2 Asia-Pacific Rheumatoid Arthritis Diagnostic Tests Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Rheumatoid Arthritis Diagnostic Tests Market Size by Region (2018-2023)
8.4 Asia-Pacific Rheumatoid Arthritis Diagnostic Tests Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rheumatoid Arthritis Diagnostic Tests Market Size (2018-2029)
9.2 Latin America Rheumatoid Arthritis Diagnostic Tests Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Rheumatoid Arthritis Diagnostic Tests Market Size by Country (2018-2023)
9.4 Latin America Rheumatoid Arthritis Diagnostic Tests Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatoid Arthritis Diagnostic Tests Market Size (2018-2029)
10.2 Middle East & Africa Rheumatoid Arthritis Diagnostic Tests Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Rheumatoid Arthritis Diagnostic Tests Market Size by Country (2018-2023)
10.4 Middle East & Africa Rheumatoid Arthritis Diagnostic Tests Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Detail
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Rheumatoid Arthritis Diagnostic Tests Introduction
11.1.4 Abbott Diagnostics Revenue in Rheumatoid Arthritis Diagnostic Tests Business (2018-2023)
11.1.5 Abbott Diagnostics Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Rheumatoid Arthritis Diagnostic Tests Introduction
11.2.4 Beckman Coulter Revenue in Rheumatoid Arthritis Diagnostic Tests Business (2018-2023)
11.2.5 Beckman Coulter Recent Development
11.3 Euro Diagnostica
11.3.1 Euro Diagnostica Company Detail
11.3.2 Euro Diagnostica Business Overview
11.3.3 Euro Diagnostica Rheumatoid Arthritis Diagnostic Tests Introduction
11.3.4 Euro Diagnostica Revenue in Rheumatoid Arthritis Diagnostic Tests Business (2018-2023)
11.3.5 Euro Diagnostica Recent Development
11.4 Hoffmann-La Roche
11.4.1 Hoffmann-La Roche Company Detail
11.4.2 Hoffmann-La Roche Business Overview
11.4.3 Hoffmann-La Roche Rheumatoid Arthritis Diagnostic Tests Introduction
11.4.4 Hoffmann-La Roche Revenue in Rheumatoid Arthritis Diagnostic Tests Business (2018-2023)
11.4.5 Hoffmann-La Roche Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Rheumatoid Arthritis Diagnostic Tests Introduction
11.5.4 Qiagen Revenue in Rheumatoid Arthritis Diagnostic Tests Business (2018-2023)
11.5.5 Qiagen Recent Development
11.6 Siemens Healthcare
11.6.1 Siemens Healthcare Company Detail
11.6.2 Siemens Healthcare Business Overview
11.6.3 Siemens Healthcare Rheumatoid Arthritis Diagnostic Tests Introduction
11.6.4 Siemens Healthcare Revenue in Rheumatoid Arthritis Diagnostic Tests Business (2018-2023)
11.6.5 Siemens Healthcare Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Detail
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Rheumatoid Arthritis Diagnostic Tests Introduction
11.7.4 Thermo Fisher Scientific Revenue in Rheumatoid Arthritis Diagnostic Tests Business (2018-2023)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Bio Rad Laboratories
11.8.1 Bio Rad Laboratories Company Detail
11.8.2 Bio Rad Laboratories Business Overview
11.8.3 Bio Rad Laboratories Rheumatoid Arthritis Diagnostic Tests Introduction
11.8.4 Bio Rad Laboratories Revenue in Rheumatoid Arthritis Diagnostic Tests Business (2018-2023)
11.8.5 Bio Rad Laboratories Recent Development
11.9 Aviva Systems Biology
11.9.1 Aviva Systems Biology Company Detail
11.9.2 Aviva Systems Biology Business Overview
11.9.3 Aviva Systems Biology Rheumatoid Arthritis Diagnostic Tests Introduction
11.9.4 Aviva Systems Biology Revenue in Rheumatoid Arthritis Diagnostic Tests Business (2018-2023)
11.9.5 Aviva Systems Biology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott Diagnostics
Beckman Coulter
Euro Diagnostica
Hoffmann-La Roche
Qiagen
Siemens Healthcare
Thermo Fisher Scientific
Bio Rad Laboratories
Aviva Systems Biology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂